NYSE:LH - New York Stock Exchange, Inc. - US5049221055 - Common Stock - Currency: USD
241.01
+0.59 (+0.25%)
The current stock price of LH is 241.01 USD. In the past month the price increased by 3.59%. In the past year, price increased by 19.71%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.44 | 92.19B | ||
CVS | CVS HEALTH CORP | 12.31 | 84.21B | ||
DGX | QUEST DIAGNOSTICS INC | 19.39 | 19.89B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.72 | 14.89B | ||
DVA | DAVITA INC | 14.9 | 11.32B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 114 | 10.98B | ||
CHE | CHEMED CORP | 24.67 | 8.50B | ||
HIMS | HIMS & HERS HEALTH INC | 61.3 | 7.35B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
CRVL | CORVEL CORP | 26.02 | 5.59B | ||
OPCH | OPTION CARE HEALTH INC | 23.76 | 5.31B | ||
RDNT | RADNET INC | 83.14 | 3.93B |
Labcorp Holdings, Inc. engages in providing medical testing services. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
LABCORP HOLDINGS INC
358 S Main St
Burlington NORTH CAROLINA 27215 US
CEO: Adam H. Schechter
Employees: 61975
Company Website: https://www.labcorp.com/
Investor Relations: http://ir.labcorp.com/
Phone: 13362291127
The current stock price of LH is 241.01 USD. The price increased by 0.25% in the last trading session.
The exchange symbol of LABCORP HOLDINGS INC is LH and it is listed on the New York Stock Exchange, Inc. exchange.
LH stock is listed on the New York Stock Exchange, Inc. exchange.
28 analysts have analysed LH and the average price target is 275.89 USD. This implies a price increase of 14.47% is expected in the next year compared to the current price of 241.01. Check the LABCORP HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LABCORP HOLDINGS INC (LH) has a market capitalization of 20.17B USD. This makes LH a Large Cap stock.
LABCORP HOLDINGS INC (LH) currently has 61975 employees.
LABCORP HOLDINGS INC (LH) has a support level at 218.29 and a resistance level at 251.54. Check the full technical report for a detailed analysis of LH support and resistance levels.
The Revenue of LABCORP HOLDINGS INC (LH) is expected to grow by 7.18% in the next year. Check the estimates tab for more information on the LH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LABCORP HOLDINGS INC (LH) has a dividend yield of 1.25%. The yearly dividend amount is currently 2.91. Check the full fundamental report for a detailed analysis of LH dividend history, reliability and sustainability.
LABCORP HOLDINGS INC (LH) will report earnings on 2025-07-30.
The PE ratio for LABCORP HOLDINGS INC (LH) is 16.36. This is based on the reported non-GAAP earnings per share of 14.73 and the current share price of 241.01 USD. Check the full fundamental report for a full analysis of the valuation metrics for LH.
The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.05% of its float. Check the ownership tab for more information on the LH short interest.
ChartMill assigns a technical rating of 7 / 10 to LH. When comparing the yearly performance of all stocks, LH is one of the better performing stocks in the market, outperforming 83.2% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has only an average score on both its financial health and profitability.
Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 14.73. The EPS increased by 4.03% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.73% | ||
ROA | 4.06% | ||
ROE | 9.26% | ||
Debt/Equity | 0.67 |
ChartMill assigns a Buy % Consensus number of 84% to LH. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 13.4% and a revenue growth 7.18% for LH